Newsletter

Sign up for our quarterly newsletter and get the newest articles from acutecaretesting.org

Printed from acutecaretesting.org

Journal Scan

January 2013

Pulse oximetry not reliable for diabetic patients?

Summarized from Pu L, Shen Y, Lu L et al. Increased blood glycohemoglobin A1c levels lead to overestimation of arterial oxygen saturation by pulse oximetry in patients with type 2 diabetes. Cardiovascular Diabetology 2012; 11: 110. As accessed: www.cardiab.com/content/11/1/110 December 2012.

Pulse oximeters, which are ubiquitous in nearly all areas of clinical care, provide the means for safe, non-invasive continuous monitoring of blood oxygen saturation. The validity of using pulse oximetry to assess patient blood oxygenation status depends on SpO2, the parameter measured by pulse oximetry, being a reliable estimate of arterial oxygen saturation (sO2(a)), the parameter directly measured during blood gas analysis. 

In most clinical contexts SpO2 is more or less equal to sO2(a), but that is not always the case and it is important to be aware of the limitations of pulse oximetry and define clinical situations when there is no alternative to blood gas analysis for accurate assessment of blood oxygenation. 

According to the results of a recent clinical study, pulse oximetry may not be suitable for assessment of blood oxygenation among type 2 diabetic patients with poor glycemic control and consequent increased HbA1c. The study population comprised 261 type 2 diabetes patients who were critically ill and required oxygen therapy and/or mechanical ventilation. 

Their care included continuous monitoring of oxygen saturation using a pulse oximeter. Fasting blood was sampled from each study patient for glucose and HbA1c. Arterial blood was sampled for blood gas analysis, including measurement of sO2(a). As arterial blood was sampled, the patient’s SpO2 reading from pulse oximeter was recorded. 

For the purposes of this study poor glycemic control was defined as HbA1c > 7.0 %; by this definition 114 of the 261 patients (44 %) had poor glycemic control. There was essentially no difference between SpO2 and sO2(a) among those with adequate glycemic control: mean SpO2 95.1 % ± 2.8 and mean sO2(a) 95.3 % ± 2.8. 

However, there was a significant difference (bias) between the two parameters among those with poor glycemic control: mean SpO2 98.0 % ± 2.6 and mean sO2(a) 96.2 % ± 2.9. The magnitude of the bias was demonstrated to correlate with HbA1c, so that the higher the HbA1c the greater is the difference between SpO2 and sO2(a). 

The authors were able to conclude that among patients with poorly controlled type 2 diabetes, pulse oximetry overestimates arterial oxygen saturation. It may be more appropriate to use arterial blood gas analysis, rather than pulse oximetry, to monitor treatment of hypoxemia in these patients.

 

Disclaimer

May contain information that is not supported by performance and intended use claims of Radiometer's products. See also Legal info.

Chris Higgins

has a master's degree in medical biochemistry and he has twenty years experience of work in clinical laboratories.

Articles by this author

Sign up for the Acute Care Testing newsletter

Sign up
About this site About Radiometer Contact us Legal notice Privacy Policy
This site uses cookies Read more